A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
about
T cell epitope regions of the P. falciparum MSP1-33 critically influence immune responses and in vitro efficacy of MSP1-42 vaccinesProtection induced by Plasmodium falciparum MSP1(42) is strain-specific, antigen and adjuvant dependent, and correlates with antibody responsesThe clinical-grade 42-kilodalton fragment of merozoite surface protein 1 of Plasmodium falciparum strain FVO expressed in Escherichia coli protects Aotus nancymai against challenge with homologous erythrocytic-stage parasites.A recombinant 15-kilodalton carboxyl-terminal fragment of Plasmodium yoelii yoelii 17XL merozoite surface protein 1 induces a protective immune response in mice.Immunological cross-reactivity of the C-terminal 42-kilodalton fragment of Plasmodium falciparum merozoite surface protein 1 expressed in baculovirus.In vitro growth-inhibitory activity and malaria risk in a cohort study in maliPlasmodium berghei circumvents immune responses induced by merozoite surface protein 1- and apical membrane antigen 1-based vaccines.Identification of the Plasmodium chabaudi homologue of merozoite surface proteins 4 and 5 of Plasmodium falciparum.Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in KoreaVaccine efficacy of recombinant Plasmodium falciparum merozoite surface protein 1 in malaria-naive, -exposed, and/or -rechallenged Aotus vociferans monkeys.Immunogenicity and efficacy in aotus monkeys of four recombinant Plasmodium falciparum vaccines in multiple adjuvant formulations based on the 19-kilodalton C terminus of merozoite surface protein 1.Characterization of conserved T- and B-cell epitopes in Plasmodium falciparum major merozoite surface protein 1.Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam.Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.Insect cells are superior to Escherichia coli in producing malaria proteins inducing IgG targeting PfEMP1 on infected erythrocytesNaturally acquired human antibodies which recognize the first epidermal growth factor-like module in the Plasmodium falciparum merozoite surface protein 1 do not inhibit parasite growth in vitro.Antibody and T cell responses in reciprocal prime-boost studies with full-length and truncated merozoite surface protein 1-42 vaccines.Comparative analysis of the profiles of IgG subclass-specific responses to Plasmodium falciparum apical membrane antigen-1 and merozoite surface protein-1 in naturally exposed individuals living in malaria hypoendemic settings, Iran.Serum antibodies from malaria-exposed people recognize conserved epitopes formed by the two epidermal growth factor motifs of MSP1(19), the carboxy-terminal fragment of the major merozoite surface protein of Plasmodium falciparumBlood stage merozoite surface protein conjugated to nanoparticles induce potent parasite inhibitory antibodiesA recombinant baculovirus 42-kilodalton C-terminal fragment of Plasmodium falciparum merozoite surface protein 1 protects Aotus monkeys against malaria.Dominance of conserved B-cell epitopes of the Plasmodium falciparum merozoite surface protein, MSP1, in blood-stage infections of naive Aotus monkeys.Influence of adjuvants on protection induced by a recombinant fusion protein against malarial infection.Natural immune response to the C-terminal 19-kilodalton domain of Plasmodium falciparum merozoite surface protein 1.Immunization of Aotus nancymai with recombinant C terminus of Plasmodium falciparum merozoite surface protein 1 in liposomes and alum adjuvant does not induce protection against a challenge infectionAcquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malariaCpG oligodeoxynucleotide and Montanide ISA 51 adjuvant combination enhanced the protective efficacy of a subunit malaria vaccineImmunization with a recombinant C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 protects mice against homologous but not heterologous P. yoelii sporozoite challenge.A second merozoite surface protein (MSP-4) of Plasmodium falciparum that contains an epidermal growth factor-like domain.Plasmodium falciparum: immunization with MSP1-42 induced non-inhibitory antibodies that have no blocking activities but enhanced the potency of inhibitory anti-MSP1-42 antibodies.Plasmodium falciparum malaria in the Peruvian Amazon, a region of low transmission, is associated with immunologic memory.Antibodies inhibit the protease-mediated processing of a malaria merozoite surface protein.Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates.Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria.Antibodies that inhibit malaria merozoite surface protein-1 processing and erythrocyte invasion are blocked by naturally acquired human antibodies.Antigenic characterization of an intrinsically unstructured protein, Plasmodium falciparum merozoite surface protein 2.Recombinant Mycobacterium bovis bacillus Calmette-Guérin secreting merozoite surface protein 1 (MSP1) induces protection against rodent malaria parasite infection depending on MSP1-stimulated interferon gamma and parasite-specific antibodies.Broadly reactive antibodies specific for Plasmodium falciparum MSP-1(19) are associated with the protection of naturally exposed children against infection.Immunogenicity and in vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys.Iron oxide nanoparticles as a clinically acceptable delivery platform for a recombinant blood-stage human malaria vaccine.
P2860
Q28740432-FE997575-1E91-4A90-879C-DEA5DF0FDFD9Q33356029-D5317F85-705F-404C-9D18-2CD79CECFD17Q33558061-1A355915-B1F2-4CBD-A5E3-0B7EE7878620Q33599911-63233AEF-ED2A-4146-BDF8-F018E81A4B6DQ33605280-B14F1701-65BB-42D6-9B73-CC2ECB140D7CQ33613892-A2D47D5E-0721-4C8E-AA81-56C2D4985061Q33742070-663FD0CE-AC25-4C6B-9B2A-7777BC652B4CQ33866574-675E70D3-6463-4342-BDCF-A052916E9AACQ33998800-D3D85B66-817D-44A9-A46F-7F81D72B190EQ34003578-958A6569-A917-4965-B8CB-3FAC862295F7Q34003987-26EAF441-145F-44B5-97FC-BA46791357FFQ34004267-1412CF59-3767-4AAC-B76D-15AB7EB2107CQ34008262-92BA28FA-C7A6-4B86-B684-AE9912A9E2D1Q34154429-575AB7BC-3132-4E6F-85C6-F58A0BB844B4Q34367020-79249366-BA30-493C-9CAD-FDBCCEB54E67Q34541366-D8AF3C5F-AB51-45C9-83A1-9B35F2FF606DQ35010158-90B22941-3C38-43D7-BD61-4D135D9208ACQ35194707-885BC87E-8FA7-4F1C-9A58-A3B0A18D99CFQ35383761-EBBD05CE-1D5C-4CCA-801E-8F079D46C2B5Q35456892-D0DC7FD9-166F-446A-8B3D-144E3E4C8308Q35463512-B22F523A-0682-4BB6-B9F8-FFEEAB5B09DDQ35486529-4F34725E-863A-4368-9787-1DB32C6382E2Q35504908-FA6C8B44-F294-44F4-B65B-7E841295DF5CQ35505807-EBC46A94-9C89-4B05-A1BC-91AD6802D415Q35516848-B4EB3479-7CF7-451A-B08D-68ED7C416CEEQ35546112-163B2CAE-565D-4972-B53A-699DA0F3E129Q35550770-DD88E52D-D26D-439B-A905-63B88C31844AQ35557454-E6547B59-3311-49BA-88AC-D86C21614221Q35557563-C126F491-9990-45B4-BC9A-F7B1968C36BDQ35762375-6F9A9620-AD9B-471C-B9F7-5AF1B9137594Q35867604-4561148A-DC88-4A80-8D01-970DC42D11EEQ36363426-EFC2AF4E-209C-46DF-B2E8-10EC7FCD4DE0Q36368017-8C3DF546-4142-4197-A49B-FA62EDDEBA07Q36368911-09101301-7E1B-4DA7-8A58-279E05494F13Q36380869-2385D7AE-0475-4FE2-80FC-9C23267CAFA3Q36396844-7A228605-C99A-4A73-8320-9DB8BC11A557Q36404193-2262D529-04DC-4F59-9233-B72192F4A523Q36411599-321C2FC0-9234-40CC-98F4-23B7AA3C890BQ36437429-0E32C5CA-922F-4D2D-BA1A-C0A77B2F52CAQ36615170-4C2D8390-31F2-4FD2-89D7-03D0876EEBB6
P2860
A carboxyl-terminal fragment of Plasmodium falciparum gp195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
1992年學術文章
@zh
1992年學術文章
@zh-hant
name
A carboxyl-terminal fragment o ...... etely inhibit parasite growth.
@en
type
label
A carboxyl-terminal fragment o ...... etely inhibit parasite growth.
@en
prefLabel
A carboxyl-terminal fragment o ...... etely inhibit parasite growth.
@en
P2093
P1476
A carboxyl-terminal fragment o ...... etely inhibit parasite growth.
@en
P2093
P304
P407
P577
1992-07-01T00:00:00Z